Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isatuximab in kidney transplant candidates
NCT04294459Phase 2Terminated
- Sponsor
- Sanofi
- Start
- Jun 2020
- Primary completion
- May 2022
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of isatuximab, sponsored by Sanofi. Started Jun 2020; status: terminated.
02
Drugs
isatuximab
Beyond the preview
Go deeper on NCT04294459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04294459.